Nexalin Technology Inc. (NXL) - Total Assets
Based on the latest financial reports, Nexalin Technology Inc. (NXL) holds total assets worth $3.69 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Nexalin Technology Inc. - Total Assets Trend (2019–2025)
This chart illustrates how Nexalin Technology Inc.'s total assets have evolved over time, based on quarterly financial data. Also see NXL stock market capitalisation for the company's overall valuation and market capitalisation.
Nexalin Technology Inc. - Asset Composition Analysis
Current Asset Composition (December 2025)
Nexalin Technology Inc.'s total assets of $3.69 Million consist of 92.8% current assets and 7.3% non-current assets. Review total liabilities of Nexalin Technology Inc. to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 14.1% |
| Accounts Receivable | $81.57K | 1.8% |
| Inventory | $131.47K | 2.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $336.05K | 7.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Nexalin Technology Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Nexalin Technology Inc. stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nexalin Technology Inc.'s current assets represent 92.8% of total assets in 2025, a decrease from 98.8% in 2019.
- Cash Position: Cash and equivalents constituted 14.1% of total assets in 2025, down from 56.4% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 7.3% of total assets.
Nexalin Technology Inc. Competitors by Total Assets
Key competitors of Nexalin Technology Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic plc
SA:MDTC34
|
Brazil | R$93.03 Billion |
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Biosynex
PA:ALBIO
|
France | €149.44 Million |
Nexalin Technology Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.07 | 4.56 | 0.18 |
| Quick Ratio | 3.85 | 4.25 | 0.17 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.48 Million | $2.05 Million | $-1.62 Million |
Nexalin Technology Inc. - Advanced Valuation Insights
This section examines the relationship between Nexalin Technology Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.51 |
| Latest Market Cap to Assets Ratio | 1.56 |
| Asset Growth Rate (YoY) | 9.8% |
| Total Assets | $4.64 Million |
| Market Capitalization | $7.25 Million USD |
Valuation Analysis
Above Book Valuation: The market values Nexalin Technology Inc.'s assets above their book value (1.56x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Nexalin Technology Inc.'s assets grew by 9.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nexalin Technology Inc. (2019–2025)
The table below shows the annual total assets of Nexalin Technology Inc. from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $4.64 Million | +9.77% |
| 2024-12-31 | $4.22 Million | +16.27% |
| 2023-12-31 | $3.63 Million | -51.13% |
| 2022-12-31 | $7.43 Million | +886.09% |
| 2021-12-31 | $753.70K | +536.24% |
| 2020-12-31 | $118.46K | +5.29% |
| 2019-12-31 | $112.51K | -- |
About Nexalin Technology Inc.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 a… Read more